Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-11-13 |
2024-09 |
0 |
N/A |
N/A |
N/A |
2024-08-07 |
2024-06 |
0 |
-0.24 |
N/A |
N/A |
2024-05-08 |
2024-03 |
0 |
-0.6 |
N/A |
N/A |
2024-05-08 |
2024-03 |
0 |
N/A |
N/A |
N/A |
2024-03-05 |
2023-12 |
0 |
N/A |
N/A |
N/A |
2024-03-05 |
2023-12 |
0 |
-0.96 |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2023-08-09 |
BTIG |
Upgrade |
Buy |
Buy |
Date |
Name |
Relation |
Quantity |
Description |
2024-06-02 |
CHAUBEY ALKA PH.D. |
Officer |
48.25K |
Stock Award(Grant) |
2024-06-02 |
DIXON JONATHAN V |
General Counsel |
18.02K |
Stock Award(Grant) |
2024-06-02 |
HOLMLIN R ERIK |
Chief Executive Officer |
122.32K |
Stock Award(Grant) |
2024-06-02 |
KAMA GULSEN |
Chief Financial Officer |
16.00K |
Stock Award(Grant) |
2023-06-12 |
MAMUSZKA HANNAH |
Director |
65.79K |
Purchase |
2024-06-02 |
OLDAKOWSKI MARK |
Chief Operating Officer |
64.70K |
Stock Award(Grant) |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Group Inc |
1.45M |
885.53K |
4.11% |
2023-06-29 |
Blackrock Inc. |
613.69K |
374.35K |
1.74% |
2023-06-29 |
Qube Research & Technologies Ltd |
393.95K |
240.31K |
1.11% |
2023-06-29 |
State Street Corporation |
383.77K |
234.10K |
1.09% |
2023-06-29 |
Mitsubishi UFJ Kokusai Asset Management Co., Ltd |
358.95K |
218.96K |
1.02% |
2023-06-29 |
Millennium Management Llc |
333.07K |
203.17K |
0.94% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
889.85K |
542.81K |
2.52% |
2023-06-29 |
Vanguard Extended Market Index Fund |
406.54K |
247.99K |
1.15% |
2023-08-30 |
SPDR (R) Ser Tr-SPDR� Kensho New Economies Composite ETF |
258.12K |
996.34K |
0.73% |
2023-05-30 |
Fidelity Extended Market Index Fund |
152.01K |
105.18K |
0.43% |
2023-09-29 |
Global X Fds-Global X Genomics & Biotechnology ETF |
136.15K |
412.53K |
0.39% |
2023-05-30 |
Schwab Strategic Tr-Schwab U.S. Small Cap ETF |
125.49K |
86.83K |
0.36% |
Split |
Date |
1 : 10 |
2023-08-07 |